Proton Beam is Losing Support
The tug-of-war continues between prostate cancer patients who want to be treated with proton beam therapy (PBT) vs. their insurance companies. As you can read from the blog below, payers are denying PCa coverage due to the high cost of the treatment coupled with lack of evidence showing superiority over conventional radiation therapies... keep reading
